HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,020,475 | -55.6% | 26,714 | -58.0% | 0.01% | -55.6% |
| Q2 2023 | $2,295,964 | -1.3% | 63,653 | +4.5% | 0.02% | -10.0% |
| Q1 2023 | $2,325,771 | +67099.4% | 60,900 | +0.1% | 0.02% | -31.0% |
| Q4 2022 | $3,461 | -99.8% | 60,827 | +11.3% | 0.03% | +31.8% |
| Q3 2022 | $2,160,000 | -10.1% | 54,627 | +0.0% | 0.02% | -15.4% |
| Q2 2022 | $2,403,000 | +16.8% | 54,612 | +5.8% | 0.03% | +30.0% |
| Q1 2022 | $2,058,000 | +9.6% | 51,597 | +10.5% | 0.02% | 0.0% |
| Q4 2021 | $1,877,000 | -1.9% | 46,677 | -0.7% | 0.02% | -9.1% |
| Q3 2021 | $1,913,000 | -5.5% | 47,024 | +5.5% | 0.02% | -4.3% |
| Q2 2021 | $2,025,000 | +14.5% | 44,588 | +5.1% | 0.02% | +4.5% |
| Q1 2021 | $1,769,000 | -2.4% | 42,421 | -0.0% | 0.02% | -15.4% |
| Q4 2020 | $1,812,000 | – | 42,434 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |